(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIODEXA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BIODEXA

ST13

US500000079380368

Classe

40, 42

Pedido

79380368

Registro

7646518

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

03/04/2026

Tipo de marca

Verbal

Classes Nice

40, 42

Data de depósito

04/09/2023

Data de registro

14/01/2025

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/01/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

RADEMACHER, APRIL LUEDERS

Unidade examinadora

L80

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

BIODEXA PHARMACEUTICALS LIMITED

Representantes

BIODEXA PHARMACEUTICALS LIMITED

Classificação técnica

Classes Nice

Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 40

Custom manufacture of pharmaceuticals; 3D printing for others; custom 3D printing for others; 3D printing for others and custom 3D printing in the fields of pharmaceuticals and medicines; 3D printing for others and custom 3D printing in the field of drug deliveryinformationadvisory and consultancy services relating to the aforesaid

Classe 42

Pharmaceutical and drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific researchdesign and analysis in the field of drug delivery; technological servicesproviding technical advice related to the manufacture of drug delivery devicesinformationadvisory and consultancy services relating to the aforesaid

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

19/02/2026

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

19/02/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

19/02/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/02/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/02/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/08/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

22/07/2025

FIMP

FINAL DISPOSITION PROCESSED

22/07/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/06/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/06/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/06/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/06/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/06/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

14/04/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

22/03/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/03/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

14/01/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

14/01/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/11/2024

PUBO

PUBLISHED FOR OPPOSITION

26/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

19/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/10/2024

RFNT

REFUSAL PROCESSED BY IB

11/06/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/05/2024

RFRR

REFUSAL PROCESSED BY MPU

20/05/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/05/2024

CNRT

NON-FINAL ACTION WRITTEN

07/05/2024

DOCK

ASSIGNED TO EXAMINER

30/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

30/11/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

30/11/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

30/11/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

30/11/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

30/11/2023

MAFR

APPLICATION FILING RECEIPT MAILED

14/10/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/10/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/10/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIODEXA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.